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Introduction
Sweet syndrome is a neutrophilic dermatosis usually
idiopathic; it may be associated in one third of cases
with inflammatory or neoplastic diseases, or subse-
quently to drug intake. Its association with pregnancy
has been rarely described. Through this observation, we
report the case of a pregnancy discovered by the etiolo-
gical diagnosis of Sweet’s syndrome.
Objectives
To emphasize on the importance of seeking pregnancy
during etiological Sweet’s syndrome in a young woman
of childbearing age.
Methods
Mrs. S.H 31 years old, whose antecedents show irregular
menstrual cycles, mechanical contraception used in anar-
chic way, was hospitalized for painful nodular erythema-
tous papulopustular lesions located in the face and limbs,
associated with fever (38.5°C) and arthralgia of the ankles.
Clinical exam showed limited papulo-nodular erythema-
tous lesions of variable size, in the face, the upper limbs
and thighs with the dermal-hypodermic nodule in legs.
Tests showed neutrophilic leukocytosis at 13000 ele-
ments/mm3, a sedimentation rate accelerated to 100mm
in the first hour and a C-reactive protein increased to
79mg/l. Liver function was normal and 24h proteinuria
was negative.
Skin biopsy was in favor of Sweet’s syndrome. An
etiological test was conducted. No abnormality was
observed for blood smear, electrophoresis of proteins,
lactate dehydrogenase dosage and carcinoembryonic
antigen. Given the gynecological history of the patient, a
dosage of Beta-HCG was performed and showed an
increase to 119358mUI/ml. Endovaginal ultrasonography
showed mono fetal pregnancy with a gestational age
estimated to six weeks. The diagnosis of pregnancy
Sweet Sydrome was retained. Therapeutic abstention
was advocated with clinical monitoring and the evolu-
tion was spontaneously favorable after 6 weeks.
Results
Sweet’s syndrome in pregnancy represents only 2% of all
etiologies of this neutrophilic dermatosis. Its pathogenesis,
likely due to a hormonal mechanism, remains unclear.
Fetal-maternal prognosis is not affected by the occurrence
of Sweet’s syndrome, the only risk is the recurrence in sub-
sequent pregnancies. Treatment consists mainly on corti-
costeroids at a dose of 0.5 to 1mg/kg/jour allowing apyrexia
and rapid regression of symptoms. In our case, no therapy
has been advocated giving the conservation of the general
condition of the patient, which resulted in a good evolution.
Conclusion
This observation shows that Sweet’s syndrome pregnancy
may occur at a very early gestational age. Seeking preg-
nancy is thus necessary in any patient of childbearing age
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